Hematologic Complications of Immune Checkpoint Inhibitors

Immune checkpoint inhibitors have improved outcomes for patients with numerous hematological and solid cancers. Hematologic toxicities have been described, but the spectrum, timing, and clinical presentation of these complications are not well understood. We used the World Health Organization's...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Davis, Elizabeth J., Salem, Joe‐Elie, Young, Arissa, Green, Jennifer R., Ferrell, P. Brent, Ancell, Kristin K., Lebrun‐Vignes, Benedicte, Moslehi, Javid J., Johnson, Douglas B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2019
Ämnen:
Immune‐Related Adverse Events
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516131/
https://ncbi.nlm.nih.gov/pubmed/30819785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0574
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk